Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.47 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | CHAT | P28329 | 5/20 | 0.36 |
| ▸ | KDM4A | O75164 | 2/20 | 0.35 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CRHBP | P24387 | 1/20 | 0.32 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18098645 | 0.88 | MEN1 (0.39) | RAB9AAPOBEC3AAPOBEC3GMEN1USP2 | |
| SCHEMBL12520800 | 0.80 | MEN1 (0.53) | RAB9AAPOBEC3AAPOBEC3GMEN1USP2 | |
| SCHEMBL11965044 | 0.78 | RAB9A (0.41) | RAB9AAPOBEC3AAPOBEC3GMEN1USP2 | |
| SCHEMBL11965047 | 0.78 | MEN1 (0.51) | RAB9AAPOBEC3AAPOBEC3GMEN1USP2 | |
| SCHEMBL11964504 | 0.77 | APOBEC3A (0.50) | RAB9AAPOBEC3AAPOBEC3GMEN1USP2 | |
| SCHEMBL12721687 | 0.76 | CHAT (0.35) | RAB9AMEN1USP2KMT2ACHAT | |
| SCHEMBL11964547 | 0.76 | RAB9A (0.52) | RAB9AAPOBEC3AAPOBEC3GMEN1USP2 | |
| SCHEMBL11965045 | 0.74 | MEN1 (0.39) | RAB9AAPOBEC3AAPOBEC3GMEN1USP2 | |
| SCHEMBL11964551 | 0.73 | RAB9A (0.38) | RAB9AAPOBEC3AAPOBEC3GMEN1USP2 | |
| SCHEMBL11964546 | 0.73 | MEN1 (0.49) | RAB9AAPOBEC3AAPOBEC3GMEN1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2488601-B1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | RICOH CO LTD (JP) | 2016-09-28 | — | — | EP | disclosed |
| US-20120194894-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | RICOH COMPANY, LTD. (JP) | 2012-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120194894-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | EED, EPX, ETV6 | RAB9A 1598/4885APOBEC3A 534/4885APOBEC3G 450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.